Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.

Abstract

Authors

• Jiangdian Song
  Sino-Dutch Biomedical and Information Engineering School, Northeastern University, Liaoning, Shenyang, 110819, China.
• Lu Wang
  Department of Laboratory, Akesu Center of Disease Control and Prevention, Akesu, China.
• Nathan Norton Ng
  Department of Radiology, School of Medicine Stanford University, Stanford, California.
• Mingfang Zhao
  Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
• Jingyun Shi
  Dept of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
• Ning Wu
  Department of Chemical and Biological Engineering, Colorado School of Mines, Golden, Colorado, USA 80401.
• Weimin Li
  Department of Psychiatry, Sleep Medicine Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
• Zaiyi Liu
  Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
• Kristen W Yeom
  Department of Radiology, Stanford University, Stanford, California, United States of America.
• Jie Tian
  CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing 100190, China.

Keywords

External Resources